RB1 and small cell lung carcinoma: Interestingly, increased E2F activity is an expected feature of SCLC due to the recurrent loss of the negative regulator RB1 in this cancer [3]; and we were able to confirm this phenotype in our own RB1 knockdown models (shown in Fig. 4B).